V Bryan Lawlis - Net Worth and Insider Trading

V Bryan Lawlis Net Worth

The estimated net worth of V Bryan Lawlis is at least $3 Million dollars as of 2024-04-19. V Bryan Lawlis is the Director of Biomarin Pharmaceutical Inc and owns about 28,950 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $3 Million. V Bryan Lawlis is also the Director of Geron Corp and owns about 0 shares of Geron Corp (GERN) stock worth over $0. Details can be seen in V Bryan Lawlis's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that V Bryan Lawlis has not made any transactions after 2023-05-11 and currently still holds the listed stock(s).

Transaction Summary of V Bryan Lawlis

To

V Bryan Lawlis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, V Bryan Lawlis owns 7 companies in total, including Spyre Therapeutics Inc (SYRE) , Geron Corp (GERN) , and Biomarin Pharmaceutical Inc (BMRN) among others .

Click here to see the complete history of V Bryan Lawlis’s form 4 insider trades.

Insider Ownership Summary of V Bryan Lawlis

Ticker Comapny Transaction Date Type of Owner
SYRE Spyre Therapeutics Inc 2018-07-13 director
GERN Geron Corp 2023-05-11 director
BMRN Biomarin Pharmaceutical Inc 2023-04-03 director
CHRS Coherus BioSciences Inc 2016-05-24 director
STRO Sutro Biopharma Inc 2018-09-26 director
HGENQ Humanigen Inc 2013-08-07 director
ARDMQ Aradigm Corp 2006-03-07 director & President

V Bryan Lawlis Latest Holdings Summary

V Bryan Lawlis currently owns a total of 2 stocks. Among these stocks, V Bryan Lawlis owns 28,950 shares of Biomarin Pharmaceutical Inc (BMRN) as of April 3, 2023, with a value of $3 Million and a weighting of 100%. V Bryan Lawlis also owns 0 shares of Geron Corp (GERN) as of May 11, 2023, with a value of $0 and a weighting of 0%.

Latest Holdings of V Bryan Lawlis

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BMRN Biomarin Pharmaceutical Inc 2023-04-03 28,950 88.63 2,565,839
GERN Geron Corp 2023-05-11 0 3.69 0

Holding Weightings of V Bryan Lawlis


V Bryan Lawlis Form 4 Trading Tracker

According to the SEC Form 4 filings, V Bryan Lawlis has made a total of 8 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 8,500 shares on April 3, 2023, which brought V Bryan Lawlis around $825,265.

According to the SEC Form 4 filings, V Bryan Lawlis has made a total of 1 transactions in Geron Corp (GERN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Geron Corp is the sale of 35,000 shares on May 11, 2023, which brought V Bryan Lawlis around $105,000.

Insider Trading History of V Bryan Lawlis

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

V Bryan Lawlis Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

V Bryan Lawlis Ownership Network

Ownership Network List of V Bryan Lawlis

No Data

Ownership Network Relation of V Bryan Lawlis


V Bryan Lawlis Owned Company Details

What does Spyre Therapeutics Inc do?

Who are the key executives at Spyre Therapeutics Inc?

V Bryan Lawlis is the director of Spyre Therapeutics Inc. Other key executives at Spyre Therapeutics Inc include Chief Financial Officer Scott L Burrows , See Remarks Heidy King-jones , and director & 10 percent owner Fairmount Healthcare Co-invest L.p. .

Spyre Therapeutics Inc (SYRE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Spyre Therapeutics Inc Insider Transactions

No Available Data

V Bryan Lawlis Mailing Address

Above is the net worth, insider trading, and ownership report for V Bryan Lawlis. Currently GuruFocus does not have mailing address information for V Bryan Lawlis.

Discussions on V Bryan Lawlis

No discussions yet.